Structural and Biochemical Aspects of Tandem GAF Domains

  • Joachim E. Schultz
Part of the Handbook of Experimental Pharmacology book series (HEP, volume 191)


The GAF domain is a small-molecule-binding-domain (SMBD) identified in >7400 proteins. However, mostly the ligands are unknown. Here we mainly deal with regulatory N-terminal tandem GAF domains, GAF-A and GAF-B, of four mammalian phosphodiesterases (PDEs) and of two cyanobacterial adenylyl cyclases (ACs) which bind cyclic nucleotides. These tandem GAFs are preceded by N-terminal sequences of variable lengths and a function of their own. In mammals, GAF domains are found only in cyclic nucleotide PDEs 2, 5, 6, 10, and 11. cAMP is the ligand for phosphodiesterase 10, cGMP for the others. Two cyanobacterial ACs, CyaB1 and 2, carry regulatory cAMP-binding tandem GAF domains which are similar in sequence to the mammalian ones. These tandem GAF domains have a prominent NKFDE motif which contributes to ligand binding in an as yet unknown manner. Contradicting structures (parallel vs. antiparallel) are available for the tandem GAF domains of PDE 2 and AC CyaB2. In addition, the structures of phosphodiesterase 5 and 10 GAF monomers with bound ligands have been solved. In all instances, cyclic nucleotide binding involves specific protein-ligand interactions within a tightly closed binding pocket and minimal solvent exposure of the ligand. The PDE tandem GAF domains can functionally substitute for the tandem of the cyanobacterial AC CyaB1; e.g. cGMP-regulation is grafted onto the AC using tandem GAFs from PDEs 2, 5 and 11. Studies of GAF domain-regulated PDEs are hampered by the identities of regulator and substrate molecules. Using AC CyaB1 as a reporter which uses ATP as a substrate solves this issue and makes the tandem GAF domains of mammalian PDEs available for detailed kinetic and mechanistic studies. In addition, drugs which potentially act on PDE regulatory domains may be assayed with such a novel test system.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aravind L, Ponting CP (1997) The GAF domain: an evolutionary link between diverse phototrans-ducing proteins. Trends Biochem Sci 22:458–459PubMedCrossRefGoogle Scholar
  2. Bruder S, Linder JU, Martinez SE, Zheng N, Beavo JA, Schultz JE (2005) The cyanobacterial tandem GAF domains from the cyaB2 adenylyl cyclase signal via both cAMP-binding sites. Proc Natl Acad Sci U S A 102:3088–3092PubMedCrossRefGoogle Scholar
  3. Bruder S, Schultz A, Schultz JE (2006) Characterization of the tandem GAF domain of human phosphodiesterase 5 using a cyanobacterial adenylyl cyclase as a reporter enzyme. J Biol Chem 281:19969–19976PubMedCrossRefGoogle Scholar
  4. Corbin JD, Turko IV, Beasley A, Francis SH (2000) Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding ac tivities. Eur J Biochem 267:2760–2767PubMedCrossRefGoogle Scholar
  5. Fink TL, Francis SH, Beasley A, Grimes KA, Corbin JD (1999) Expression of an active, monomeric catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase (PDE5). J Biol Chem 274:34613–34620PubMedCrossRefGoogle Scholar
  6. Francis SH, Bessay EP, Kotera J, Grimes KA, Liu L, Thompson WJ, Corbin JD (2002) Phospho- rylation of isolated human Phosphodiesterase-5 regulatory domain induces an apparent confor-mational change and increases cGMP binding affinity. J Biol Chem 277:47581–47587PubMedCrossRefGoogle Scholar
  7. Granovsky AE, Natochin M, McEntaffer RL, Haik TL, Francis SH, Corbin JD, Artemyev NO (1998) Probing domain functions of chimeric PDE6alpha'/PDE5 cGMP-phosphodiesterase. J Biol Chem 273:24485–24490PubMedCrossRefGoogle Scholar
  8. Gross-Langenhoff M, Hofbauer K, Weber J, Schultz A, Schultz JE (2006) cAMP is a ligand for the tandem GAF domain of human phosphodiesterase 10 and cGMP for the tandem GAF domain of phosphodiesterase 11. J Biol Chem 281:2841–2846PubMedCrossRefGoogle Scholar
  9. Gross-Langenhoff M, Stenzl A, Altenberend F, Schultz A, Schultz JE (2008) The properties of the phosphodiesterase 11A4 GAF domains are regulated by modi-fications in its N-terminal domain. FEBS J 275:1643–1650PubMedCrossRefGoogle Scholar
  10. Handa N, Mizohata E, Kishishita S, Toyama M, Morita S, Uchikubo-Kamo T, Akasaka R, Omori K, Kotera J, Terada T, Shirouzu M, Yokoyama S (2008) Crystal Structure of the GAF-B Domain from Human Phosphodiesterase 10A Complexed with Its Ligand, cAMP. J Biol Chem 283:19657–19664PubMedCrossRefGoogle Scholar
  11. Hofbauer K, Schultz A, Schultz JE (2008) Functional Chimeras of the Phosphodiesterase 5 and 10 Tandem GAF Domains. J Biol Chem 283:25164–25170PubMedCrossRefGoogle Scholar
  12. Ho YS, Burden LM, Hurley JH (2000) Structure of the GAF domain, a ubiquitous signaling motif and a new class of cyclic GMP receptor. EMBO J 19:5288–5299PubMedCrossRefGoogle Scholar
  13. Kanacher T, Schultz A, Linder JU, Schultz JE (2002) A GAF-domain-regulated adenylyl cyclase from Anabaena is a self-activating cAMP switch. EMBO J 21:3672–3680PubMedCrossRefGoogle Scholar
  14. Linder JU, Bruder S, Schultz A, Schultz JE (2007) Changes in purine specificity in tandem GAF chimeras from cyanobacterial cyaB1 adenylate cyclase and rat phosphodiesterase 2. FEBS J 274:1514–1523PubMedCrossRefGoogle Scholar
  15. Martinez SE, Beavo JA, Hol WG (2002a) GAF domains: two-billion-year-old molecular switches that bind cyclic nucleotides. Mol Interv 2:317–323CrossRefGoogle Scholar
  16. Martinez SE, Wu AY, Glavas NA, Tang XB, Turley S, Hol WG, Beavo JA (2002b) The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding. Proc Natl Acad Sci U S A 99:13260–13265CrossRefGoogle Scholar
  17. Martinez SE, Bruder S, Schultz A, Zheng N, Schultz JE, Beavo JA, Linder JU (2005) Crystal structure of the tandem GAF domains from a cyanobacterial adenylyl cyclase: modes of ligand binding and dimerization. Proc Natl Acad Sci U S A 102:3082–3087PubMedCrossRefGoogle Scholar
  18. McAllister-Lucas LM, Haik TL, Colbran JL, Sonnenburg WK, Seger D, Turko IV, Beavo JA, Francis SH, Corbin JD (1995) An essential aspartic acid at each of two allosteric cGMP-binding sites of a cGMP-specific phosphodiesterase. J Biol Chem 270:30671–30679CrossRefGoogle Scholar
  19. Mou H, Cote RH (2001) The catalytic and GAF domains of the rod cGMP phosphodiesterase (PDE6) heterodimer are regulated by distinct regions of its inhibitory gamma subunit. J Biol Chem 276:27527–27534PubMedCrossRefGoogle Scholar
  20. Mou H, Grazio HJ III, Cook TA, Beavo JA, Cote RH (1999) cGMP binding to noncatalytic sites on mammalian rod photoreceptor phosphodiesterase is regulated by binding of its gamma and delta subunits. J Biol Chem 274:18813–18820PubMedCrossRefGoogle Scholar
  21. Okada D, Asakawa S (2002) Allosteric activation of cGMP-specific, cGMP-binding phosphodi-esterase (PDE5) by cGMP. Biochemistry 41: 9672–9679PubMedCrossRefGoogle Scholar
  22. Rybalkin SD, Rybalkina IG, Feil R, Hofmann F, Beavo JA (2002) Regulation of cGMP- specific Phosphodiesterase (PDE5) phoshorylation in smooth muscle cells. J Biol Chem 277: 3310–3317PubMedCrossRefGoogle Scholar
  23. Rybalkin SD, Rybalkina IG, Shimizu-Albergine M, Tang XB, Beavo JA (2003) PDE5 is converted to an activated state upon cGMP binding to the GAF A domain. EMBO J 22:469–478PubMedCrossRefGoogle Scholar
  24. Sinha SC, Wetterer M, Sprang SR, Schultz JE, Linder JU (2005) Origin of asymmetry in adenylyl cyclases: structures of Mycobacterium tuberculosis Rv1900c. EMBO J 24:663–673PubMedCrossRefGoogle Scholar
  25. Soderling SH, Bayuga SJ, Beavo JA (1999) Isolation and characterization of a dual-substrate phos-phodiesterase gene family: PDE10A. Proc Natl Acad Sci U S A 96:7071–7076PubMedCrossRefGoogle Scholar
  26. Sopory S, Balaji S, Srinivasan N, Visweswariah SS (2003) Modeling and mutational analysis of the GAF domain of the cGMP-binding, cGMP-specific phosphodiesterase, PDE5. FEBS Lett 539:161–166PubMedCrossRefGoogle Scholar
  27. Steegborn C, Litvin TN, Levin LR, Buck J, Wu H (2005) Bicarbonate activation of adenylyl cyclase via promotion of catalytic active site closure and metal recruitment. Nat Struct Mol Biol 12: 32–37PubMedCrossRefGoogle Scholar
  28. Sunahara RK, Tesmer JJ, Gilman AG, Sprang SR (1997) Crystal structure of the adenylyl cyclase activator Gsalpha. Science 278:1943–1947PubMedCrossRefGoogle Scholar
  29. Tesmer JJG, Sunahara RK, Johnson RA, Gosselin G, Gilman AG, Sprang SR (1999) Two-metal-ion catalysis in adenylyl cyclase. Science 285:756–760PubMedCrossRefGoogle Scholar
  30. Tews I, Findeisen F, Sinning I, Schultz A, Schultz JE, Linder JU (2005) The structure of a pH-sensing mycobacterial adenylyl cyclase holoenzyme. Science 308:1020–1023PubMedCrossRefGoogle Scholar
  31. Thomas MK, Francis SH, Corbin JD (1990) Substrate- and kinase-directed regulation of phospho-rylation of a cGMP-binding phosphodiesterase by cGMP. J Biol Chem 265:14971–14978PubMedGoogle Scholar
  32. Turko IV, Haik TL, McAllister-Lucas LM, Burns F, Francis SH, Corbin JD (1996) Identification of key amino acids in a conserved cGMP-binding site of cGMP-binding phosphodiesterases. A putative NKXnD motif for cGMP binding. J Biol Chem 271:22240–22244PubMedCrossRefGoogle Scholar
  33. Turko IV, Francis SH, Corbin JD (1998a) Binding of cGMP to both allosteric sites of cGMP-binding cGMP-specific phosphodiesterase (PDE5) is required for its phosphorylation. Biochem J 329(Pt 3):505–510Google Scholar
  34. Turko IV, Francis SH, Corbin JD (1998b) Potential roles of conserved amino acids in the catalytic domain of the cGMP-binding cGMP-specific phosphodiesterase. J Biol Chem 273:6460–6466CrossRefGoogle Scholar
  35. Wu AY, Tang XB, Martinez SE, Ikeda K, Beavo JA (2004) Molecular determinants for cyclic nucleotide binding to the regulatory domains of phosphodiesterase 2A. J Biol Chem 279: 37928–37938PubMedCrossRefGoogle Scholar
  36. Yuasa K, Kotera J, Fujishige K, Michibata H, Sasaki T, Omori K (2000) Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression. J Biol Chem 275:31469–31479PubMedCrossRefGoogle Scholar
  37. Zhang G, Liu Y, Ruoho AE, Hurley JH (1997) Structure of the adenylyl cyclase catalytic core. Nature 386:247–253PubMedCrossRefGoogle Scholar
  38. Zoraghi R, Corbin JD, Francis SH (2004) Properties and functions of GAF domains in cyclic nucleotide phosphodiesterases and other proteins. Mol Pharmacol 65:267–278PubMedCrossRefGoogle Scholar
  39. Zoraghi R, Bessay EP, Corbin JD, Francis SH (2005) Structural and functional features in human PDE5A1 regulatory domain that provide for allosteric cGMP binding, dimerization, and regulation. J Biol Chem 280:12051–12063PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2009

Authors and Affiliations

  • Joachim E. Schultz
    • 1
  1. 1.Pharmazeutisches Institut der Universität TübingenTübingenGermany

Personalised recommendations